Expert Review of Clinical Pharmacology, Volume 16, Issue 11 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Clinical Pharmacology, Volume 16, Issue 11 (2023)

See all volumes and issues
Vol 17, 2024 Volume 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Editorial

Editorial
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era
Fatima Faraz, Mohammad Ebad Ur Rehman, Abia Shahid, Muhammad Saqib Ghafoor & Huzaifa Ahmad Cheema
Pages: 1017-1019
Published online: 22 Nov 2023
First Page PreviewforNirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era | Full Text | References | PDF (203.2 KB) | EPUB
  • 904 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Key Paper Evaluation

Review Article
The new evidence on cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: one step closer to their use in this setting?
Djordje S. Popovic, Theocharis Koufakis, Dimitrios Patoulias & Nikolaos Papanas
Pages: 1021-1023
Published online: 22 Nov 2023
AbstractforThe new evidence on cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: one step closer to their use in this setting? | Full Text | References | PDF (151 KB) | EPUB
  • 246 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Report
Emerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension
Melisande L Addison, Priyanga Ranasinghe & David J Webb
Pages: 1025-1033
Published online: 22 Nov 2023
AbstractforEmerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension | Full Text | References | PDF (1.3 MB) | EPUB
  • 911 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan
Milo Gatti & Federico Pea
Pages: 1035-1051
Published online: 22 Nov 2023
AbstractforThe expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan | Full Text | References | PDF (3.8 MB) | EPUB
  • 105 Views
  • 1 CrossRef citations
  • 0Altmetric
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André J Scheen
Pages: 1053-1062
Published online: 22 Nov 2023
AbstractforBridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized? | Full Text | References | PDF (777.8 KB) | EPUB
  • 256 Views
  • 1 CrossRef citations
  • 0Altmetric

Review

Review Article
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
Chara Tsiampali, Paraskevi Papaioannidou, Antonis Goulas & Stergios A. Polyzos
Pages: 1063-1072
Published online: 22 Nov 2023
AbstractforThe role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease | Full Text | References | PDF (506.9 KB) | EPUB
  • 295 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases
Jean-Luc Balligand & Lauriane Y. M. Michel
Pages: 1073-1084
Published online: 22 Nov 2023
AbstractforClinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases | Full Text | References | PDF (4 MB) | EPUB
  • 116 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia
Jie Wu, Angela TH Kwan, Taeho Greg Rhee, Roger Ho, Giacomo d’Andrea, Giovanni Martinotti, Kayla M Teopiz, Felicia Ceban & Roger S McIntyre
Pages: 1085-1092
Published online: 22 Nov 2023
AbstractforA narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia | Full Text | References | PDF (309.6 KB) | EPUB
  • 208 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective
Luke J Ney, Wole Akosile, Chris Davey, Louise Pitcher, Kim L Felmingham, Leah M Mayo, Matthew N Hill & Esben Strodl
Pages: 1093-1108
Published online: 22 Nov 2023
AbstractforChallenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective | Full Text | References | PDF (421.5 KB) | EPUB
  • 203 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Stimulant and hallucinogenic novel psychoactive substances; an update
F Schifano, A Vento, N Scherbaum & A Guirguis
Pages: 1109-1123
Published online: 22 Nov 2023
AbstractforStimulant and hallucinogenic novel psychoactive substances; an update | Full Text | References | PDF (391.1 KB) | EPUB
  • 2572 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders
Matthew Driban, Nikita Kedia, Supriya Arora & Jay Chhablani
Pages: 1125-1139
Published online: 22 Nov 2023
AbstractforNovel pharmaceuticals for the management of retinal vein occlusion and linked disorders | Full Text | References | PDF (6.3 MB) | EPUB
  • 149 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Review Article
The efficacy and toxicity of mirvetuximab soravtansine, a novel antibody-drug conjugate, in the treatment of advanced or recurrent ovarian cancer: a meta-analysis
Ke Xu, Tianlei Wang, Shenbin Pan & Jie He
Pages: 1141-1152
Published online: 22 Nov 2023
AbstractforThe efficacy and toxicity of mirvetuximab soravtansine, a novel antibody-drug conjugate, in the treatment of advanced or recurrent ovarian cancer: a meta-analysis | Full Text | References | PDF (3 MB) | EPUB | Supplemental
  • 2283 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials
Aws Khalid Abushanab, Mus’ab Theeb Mustafa, Mahmoud Taysir Mousa, Rana Ahmed Qawaqzeh, Ghaith Nahar Alqudah & Renad Fawwaz Albanawi
Pages: 1153-1161
Published online: 22 Nov 2023
AbstractforEfficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials | Full Text | References | PDF (3.3 MB) | EPUB | Supplemental
  • 181 Views
  • 0 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Page: i
Published online: 17 Aug 2023
CitationforCorrection | Full Text | PDF (97.7 KB) | EPUB
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles